title: [Adjuvant treatment for colon carcinoma. Results and perspectives].
authors.affiliation: Medizinische Klinik I, Friedrich-Alexander-Universität Erlangen.
authors.forename: A
authors.initials: A
authors.lastname: Wein
authors.forename: C
authors.initials: C
authors.lastname: Riedel
authors.forename: T
authors.initials: T
authors.lastname: Lehnert
authors.forename: R
authors.initials: R
authors.lastname: Wakker
authors.forename: B
authors.initials: B
authors.lastname: Reingruber
authors.forename: W
authors.initials: W
authors.lastname: Teichmann
authors.forename: R
authors.initials: R
authors.lastname: Kohnen
authors.forename: C
authors.initials: C
authors.lastname: Herfarth
authors.forename: W
authors.initials: W
authors.lastname: Hohenberger
authors.forename: E G
authors.initials: EG
authors.lastname: Hahn
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000931:Antidotes / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005472:Fluorouracil / Q000008:administration & dosage; D005858:Germany; D006801:Humans; D007167:Immunotherapy; D002955:Leucovorin / Q000008:administration & dosage; D007978:Levamisole / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012955:Societies, Medical
chemical_list: D000276:Adjuvants, Immunologic; D000931:Antidotes; D000964:Antimetabolites, Antineoplastic; D007978:Levamisole; D002955:Leucovorin; D005472:Fluorouracil
vernacular_title: Adjuvante Behandlung beim Kolonkarzinom. Resultate und Perspektiven.